Hedgehog antagonist with potential in BCC identified at Curis using novel screening assays April 16, 2002
Health Canada approves phase I/II Reolysin trial in patients with recurrent malignant glioma April 15, 2002
Cephalon designs new inhibitors of VEGF-dependent angiogenesis with good oral antitumor activity April 15, 2002
RSS